Telomere length crucial in muscular dystrophy
Telomeres shorten in heart muscle cells from people with Duchenne muscular dystrophy. A Stanford Medicine study finds blocking this process improves the health of these cells grown in a dish.
A genetic variant that inhibits alcohol metabolism harms blood vessel cells, but an antidiabetic medication may mitigate the harm, Stanford Medicine-led research has found.
Immune cells become cancer killers
Neutrophils often suppress the immune system’s response to cancer, but when activated, they eliminate several types of tumors in laboratory mice, a study led by Stanford Medicine has found.
Stanford Medicine on social determinants of health
The new issue of Stanford Medicine magazine features articles about the ways nonmedical factors can help or hinder our health and presents initiatives to promote health equity.
Diabetes expert training program
Stanford Medicine recently became the national center for a program to improve the diversity and increase the number of physician-scientists who are experts in Type 1 diabetes.
Medical school withdraws from U.S. News rankings
School of Medicine withdraws from the news organization’s “Best Medical Schools” survey and rankings, citing methodology limitations.
Blood drop yields lots of data
Using a new technique called multi-omic microsampling, Stanford Medicine researchers can measure thousands of protein, fat and metabolic molecules from a single drop of blood.
$18 million for transplant and gene-editing research
The California Institute for Regenerative Medicine has funded Stanford Medicine projects to improve kidney transplantation and advance treatment for a rare genetic disease in children.
New way to treat COVID-19 smell loss
In a trial led by Stanford Medicine researchers, more than half of patients with persistent smell loss saw improvement with injections of platelet-rich plasma.
Stanford and Invus collaborate
The collaboration will enable the development of medications to treat a type of brain cancer.